345 related articles for article (PubMed ID: 7683622)
1. The role of haematopoietic growth factors in the treatment of myelodysplastic syndromes.
Rossi Ferrini P; Santini V; Ciolli S; Grossi A; Leoni F; Rafanelli D; Vannucchi AM
Hematol Oncol; 1993; 11 Suppl 1():32-5. PubMed ID: 7683622
[No Abstract] [Full Text] [Related]
2. Treatment of myelodysplastic syndromes with hemopoietic growth factors.
Greenberg PL
Semin Oncol; 1992 Feb; 19(1):106-14. PubMed ID: 1371018
[No Abstract] [Full Text] [Related]
3. Clinical use of hematopoietic growth factors in the myelodysplastic syndromes.
Ganser A; Hoelzer D
Semin Hematol; 1996 Jul; 33(3):186-95. PubMed ID: 8819229
[No Abstract] [Full Text] [Related]
4. The role of hematopoietic growth factors in the treatment of neoplastic diseases.
St Onge J; Jacobson RJ
Semin Hematol; 1992 Jul; 29(3 Suppl 2):53-63. PubMed ID: 1380737
[No Abstract] [Full Text] [Related]
5. Treatment of myelodysplastic syndromes with hematopoietic growth factors.
Ganser A; Hoelzer D
Hematol Oncol Clin North Am; 1992 Jun; 6(3):633-53. PubMed ID: 1377194
[TBL] [Abstract][Full Text] [Related]
6. [Clinical use of hematopoietic growth factors].
Robak T
Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):365-8. PubMed ID: 1279638
[No Abstract] [Full Text] [Related]
7. Hematopoietic growth factor therapy of myelodysplastic syndromes.
Arcenas AG; Vadhan-Raj S
Leuk Lymphoma; 1993; 11 Suppl 2():65-9. PubMed ID: 7510197
[No Abstract] [Full Text] [Related]
8. Hematopoietic growth factors for the treatment of myelodysplastic syndromes.
Hast R; Bernell P
Acta Haematol Pol; 1991; 22(2):203-7. PubMed ID: 1726768
[No Abstract] [Full Text] [Related]
9. Haematopoietic growth factors and their therapeutic use.
Wadhwa M; Thorpe R
Thromb Haemost; 2008 May; 99(5):863-73. PubMed ID: 18449415
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic growth factors in autologous bone marrow transplantation.
Miller AM
Semin Oncol; 1993 Oct; 20(5 Suppl 6):88-95. PubMed ID: 7692607
[TBL] [Abstract][Full Text] [Related]
11. [Hematopoietic growth factors. Current status of therapy].
Hiddemann W
Internist (Berl); 1994 Apr; 35(4):395-400. PubMed ID: 7515381
[No Abstract] [Full Text] [Related]
12. Hematopoietic growth factors in myelodysplastic syndromes.
Blinder VS; Roboz GJ
Curr Hematol Rep; 2003 Nov; 2(6):453-8. PubMed ID: 14561388
[TBL] [Abstract][Full Text] [Related]
13. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
[TBL] [Abstract][Full Text] [Related]
14. Clinical uses of hematopoietic growth hormones in HIV-related illnesses.
Mitsuyasu RT
AIDS Clin Rev; 1993-1994; ():189-212. PubMed ID: 7692940
[No Abstract] [Full Text] [Related]
15. Hematopoietic colony-stimulating factors.
Andreeff M; Welte K
Semin Oncol; 1989 Jun; 16(3):211-29. PubMed ID: 2471272
[No Abstract] [Full Text] [Related]
16. Aspects on the clinical use of hematopoietic growth factors in myelodysplastic syndromes.
Hast R; Eriksson M; Jakovleva K
Pol Arch Med Wewn; 1998 Feb; 99(2):144-9. PubMed ID: 9686516
[No Abstract] [Full Text] [Related]
17. A European perspective on haematopoietic growth factors in haemato-oncology: report of an expert meeting of the EORTC.
Croockewit AJ; Bronchud MH; Aapro MS; Bargetzi MJ; Crown J; Gratwohl A; Lange W; Ludwig H; Martinelli G; Mertelsmann R; Nuessler V; Willemze R; De Witte TJ; Zittoun R; Zwierzina H
Eur J Cancer; 1997 Oct; 33(11):1732-46. PubMed ID: 9470826
[No Abstract] [Full Text] [Related]
18. Hematopoietic growth factors in cancer chemotherapy.
Crawford J; Foote M; Morstyn G
Cancer Chemother Biol Response Modif; 1999; 18():250-67. PubMed ID: 10800487
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic use of hematopoietic growth factors.
Costa JJ
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):1-6. PubMed ID: 9449493
[No Abstract] [Full Text] [Related]
20. In vitro enhancement of erythropoiesis by steel factor in Diamond-Blackfan anemia and treatment of other congenital cytopenias with recombinant interleukin 3/granulocyte-macrophage colony stimulating factor.
Sieff C; Guinan E
Stem Cells; 1993 Jul; 11 Suppl 2():113-22. PubMed ID: 7691316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]